Medication use in the neonatal intensive care unit

PMC full text:

Published in final edited form as:

Am J Perinatol. 2014 Oct; 31(9): 811–822.

Published online 2013 Dec 17. doi: 10.1055/s-0033-1361933

Table 3

Greatest relative increase in exposure between 2005 and 2010 (≥1/1000 infant exposures in 2010)

Rank	Medication	% Change	Exposure (2005)^*	Exposure (2010)^*
1	Azithromycin	2900	0.1	3.0
2	Sildenafil	1050	0.2	2.3
3	Milrinone	900	0.4	4.0
4	Ibuprofen	650	1.4	11
5	Linezolid	500	0.4	2.4
6	Cefoxitin	350	0.4	1.8
7	Methadone	158	3.1	8.0
8	Vitamin A	152	8.3	21
9	Hyaluronidase	107	1.5	3.1
10	Poractant alpha	101	32	63
11	Meropenem	100	4.5	9.0
12	Piperacillin/tazobactam	97	6.2	12
13	Cefepime	70	4.6	7.8
14	Famotidine	60	4.7	7.5
15	Lansoprazole	58	9.8	16
16	Fluconazole	44	14	21
17	Diazepam	44	1.6	2.3
18	Nitric oxide	42	8.9	13
19	Cefazolin	38	6.3	8.7
20	Prednisone/Prednisolone	36	3.9	5.3

^*Per 1000 infants.